New VP&S Faculty

The VP&S Office of Faculty Affairs has provided this list of full-time faculty who joined the medical school in Dec. 2025:

• Hilary S. Currie, MD, OB-GYN: Currie is a board-certified obstetrician and gynecologist providing comprehensive, evidence-based care at NewYork-Presbyterian Medical Group Westchester. Her research interests have focused on maternal health, contraceptive choices, and surgical outcomes.
• Jordan A. Francke, MD, MPH, Anesthesiology: Francke's research and clinical interests include medical simulation and education, global anesthesia and capacity building, pain during Cesarean delivery, neuraxial adjuncts, and obstetric anesthesia best practices.
• Leah Hotchkiss, PsyD, Psychiatry: Hotchkiss is a clinical psychologist in the Lieber Recovery Clinic. Her clinical interests include gender, sexuality, reproductive health, mindfulness, trauma, and psychosis. She completed her dissertation in postpartum medical trauma at Lucile Packard Children's Hospital at Stanford.
• Saurabh Kapoor, MD, Medicine: Kapoor is a board-certified advanced heart failure and transplant cardiologist with particular expertise in infiltrative cardiomyopathies, including cardiac amyloidosis and sarcoidosis. His clinical interests also include mechanical circulatory support (LVAD and ECMO) and pulmonary hypertension. His work focuses on advancing the diagnosis and management of cardiac amyloidosis and other infiltrative diseases, including participation in landmark clinical trials evaluating novel disease-modifying therapies.
• Daphna A. Mezad Koursh, MD, Ophthalmology: Mezad-Koursh, MD, is a pediatric ophthalmologist and strabismus surgeon with expertise in complex strabismus, amblyopia, and pediatric refractive disorders. Her clinical interests and research focus on improving visual outcomes in children through innovations in strabismus surgery, vision screening, amblyopia prevention, and the development of data-driven and artificial intelligence–based tools to predict strabismus surgery outcomes.
• Sara Mobasseri-Egoavil, MD, Medicine: Mobasseri-Egoavil is board-certified in adult cardiovascular medicine, nuclear cardiology, and adult echocardiography. She brings more than two decades of clinical expertise, academic leadership, and program development to her roles, with a career distinguished by her commitment to advancing women's heart health and structural cardiac imaging.
• Simi A. Philip, MD, Medicine: Philip is a board-certified infectious disease and internal medicine physician with extensive experience in managing complex infections. Her clinical interests include HIV care, antimicrobial stewardship, and infectious diseases education.
• Gabriela Rodrigues, PhD, Psychiatry: Rodrigues is a licensed clinical psychologist providing cognitive-behavioral therapy for anxiety and related disorders, obsessive-compulsive disorder, school avoidance, and mood and disruptive behavior disorders. Her research interests focus on parent-child attachment and the development of children’s positive traits and its relation to children’s internalizing symptoms.
• Bertin D. Salguero Porres, MD, Medicine: Salguero is an interventional pulmonologist who focuses on state-of-the-art minimally invasive procedures including robotic bronchoscopy for the diagnosis of early lung cancer, airway complications of cancer, and pleural disease. His research is focused on therapeutic bronchoscopy, malignant pleural disease, and medical education.
• Angela M. Sturdivant, MD, OB-GYN: Sturdivant is board-certified by the American Board of Obstetrics and Gynecology and practices the full scope of obstetrics and gynecology at NYP Westchester.
• Lili Wang, MD, PhD, Medicine: Wang’s research centers on the molecular mechanisms driving hematologic malignancies, with a particular emphasis on chronic lymphocytic leukemia (CLL) and aggressive lymphoma transformation. Wang’s laboratory investigates how RNA splicing factor mutations and dysregulation of RNA splicing and RNA epigenetic programs contribute to malignant transformation, disease progression, and therapeutic vulnerability in B-cell malignancies.